GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

lerodalcibep   Click here for help

GtoPdb Ligand ID: 14319

Synonyms: LIB-003 | LIB003 | sequence 3 [US10738102B2]
Approved drug
lerodalcibep is an approved drug
Compound class: Peptide
Comment: Lerodalcibep (LIB003) is a small protein that fuses an adnectin (designed to bind proprotein convertase subtilisin/kexin type 9 [PCSK9]) to human serum albumin to achieve an extended circulating half-life and ambient storage stability [3]. It behaves as a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor [1,4-6].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
Classification Click here for help
Compound class Peptide
Approved drug? Yes. US FDA (2025)
International Nonproprietary Names Click here for help
INN number INN
11209 lerodalcibep
Synonyms Click here for help
LIB-003 | LIB003 | sequence 3 [US10738102B2]
Database Links Click here for help
GtoPdb PubChem SID 523352111
Search PubMed clinical trials lerodalcibep
Search PubMed titles lerodalcibep
Search PubMed titles/abstracts lerodalcibep